Protocol for Systematic Review and Meta-Analysis on the Efficacy and Safety of Tocilizumab

Abstract

Asim Ahmed Elnour, Adel Sadeq, Farah Hamad Farah, IsraaYousif Khidir, Doaa Nassar, Islam Mohammed Abd Allah, Jamila Alaryani, Judit Don, Mohamed Elamin Hassan, Nadeen Ali, Salma Mohamed Magboul, Noor Alhuda Kassem, Haia Abdulsamad, Warda Salah Mohammed Elkhalifa, Ekrima Elmoeiz Gaffar Osman, Hanan Siddig Ali Alamin, Hagar Awad Abdelrahim, Sahar Asim Ahmed Elnour, Asil Adel, Abubakar B. Abubakar, Abdelgadir Elamin, Abdulla Al Amoodi, Sasha Mohammed Elamin Suliman, Noora Alhajri

Background: Tocilizumab is a novel interleukin-6 inhibitor that possesses some advantages over the other members of the class and over conventional therapy for rheumatoid arthritis. Aim of the review: The aim of the current protocol for the systematic review and meta-analysis is to assess the efficacy and safety of tocilizumab. Methods: The protocol has been developed based on the PRISMA-P checklist by using (PICO [population, intervention, comparators, and outcome]) items, for adult subjects who have received tocilizumab in randomized clinical trials. We will search Google Scholar, PubMed, and the Cochrane Central Register for randomized controlled clinical trials using specific MESH terms. The subjects with rheumatoid arthritis (population) receiving tocilizumab (intervention) will be compared to placebo or other interleukin-6 inhibitors (comparators), for the non-inferiority or superiority in terms of effects on disability and/or other disease clinical markers (outcome). The RevMan will be used to quantify the synthesis of data. Whereas I2 index, tau squared, and the Q-test P value will be used to examine heterogeneity among individual study effect sizes. Anticipated results: We will present the systematic review results and the meta-analysis results in complete tables based on PICO comparison between the included trials. The results will contain a systematic critical evaluation of the included RCT-s in terms of the number of the population (characteristics), the dosing of intervention (tocilizumab) and the comparators, the main outcome measures. The necessary elements of PRISMA will be strictly followed to report the systematic review. The meta-analysis will be reported with the Cochrane guidelines in synthesis of RCT-s and all forms will be based on the quality measures as per the validated Cochrane templates. Conclusion: This protocol will report the differences in the efficacy and safety of tocilizumab (intervention) as compared to the placebo or other interleukin6 inhibitors (comparators).

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3
bandar togel terpercaya
agen togel terpercaya
situs togel bri online resmi terbaik dan terpercaya
aplikasi judi togel
daftar bandar lotre togel
bo togel deposit pulsa murah
Agen Togel Play Resmi
KEPO4D Toto Online Deposit Via Dana
bandar togel hadiah terbesar dan terpercaya DAPURTOTO
Daftar Togel Online Terbaik dan Terbesar
bandar togel terpercaya
agen togel online terpercaya
slot online gacor terbaik 2022 LAKU4D
bandar toto togel
Toto Togel laku4d
Situs Slot
Bandar Togel Online
Situs Bandar Togel
Bandar Togel 4D
Prediksi Togel Jitu
Situs Bandar Togel 4D
Bandar Togel 4D
Bandar Togel terlengkap
Bandar Togel online24jam
Bandar Togel hadiah 4d 10 juta
agen togel terpercaya
slot online dan judi bola dewa118
Situs Togel Online
Bandar Togel toto 4d terlengkap
data Sidney
toto slot
link alternatif situs togel
Situs Togel dan Toto Slot Online
bandar togel hadiah 4d 10 juta
toto hk
togel
data sdy
togel sgp
data togel sgp
bandar togel 4d dan slot deposit pulsa terpercaya
toto sgp
toto hk
togel hk
bandar togel
bandar togel 4d
togel 4d
situs togel deposit pulsa
toto online
BO Togel
BO Togel Toto HK
bandar togel 4d
totoslot 4d
situs togel resmi dan terpercaya
bandar togel bolak balik dibayar
agen togel online
Bandar Judi Mesin Slot Toto Togel 4D